KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of LXRX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Lexicon Pharmaceuticals stock price ended at $1.58 on Friday, after gaining 2.60%.
(Updated on Apr 26, 2024)

Sell candidate since Mar 21, 2024 Loss -34.44% PDF

The Lexicon Pharmaceuticals stock price gained 2.60% on the last trading day (Friday, 26th Apr 2024), rising from $1.54 to $1.58. During the last trading day the stock fluctuated 5.23% from a day low at $1.53 to a day high of $1.61. The price has fallen in 6 of the last 10 days and is down by -19.8% for this period. Volume fell on the last day by -386 thousand shares and in total, 1 million shares were bought and sold for approximately $1.98 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -20.27% during the next 3 months and, with a 90% probability hold a price between $0.81 and $2.38 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

LXRX Signals & Forecast

Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Lexicon Pharmaceuticals stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.62 and $2.09. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, February 15, 2024, and so far it has fallen -55.87%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Lexicon Pharmaceuticals stock

Lexicon Pharmaceuticals finds support from accumulated volume at $1.54 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0800 between high and low, or 5.23%. For the last week, the stock has had daily average volatility of 7.43%.

Lexicon Pharmaceuticals is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (LXRX) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Lexicon Pharmaceuticals to open at $1.57, and during the day (based on 14 day Average True Range), to move between $1.43 and $1.73, which gives a possible trading interval of +/-$0.153 (+/-9.71%) up or down from last closing price. If Lexicon Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 19.43% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $1.62 (2.53%) than the support at $1.54 (2.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Lexicon Pharmaceuticals stock A Buy?

Lexicon Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.501 Strong Sell Candidate Unchanged

Predicted Opening Price for Lexicon Pharmaceuticals of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$1.57 ( 0.422%) $1.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for LXRX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.65 4.64 %
R2 1.62 2.71 %
R1 1.60 1.51 %
Current price: 1.58
Support S1 1.54 -2.36 %
S2 1.52 -3.55 %
S3 1.49 -5.49 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.87 18.35 %
R2 1.70 7.28 %
R1 1.62 2.53 %
Current price 1.58
Support S1 1.54 -2.53%
S2 0 .
S3 0 .

FAQ

What is the symbol for Lexicon Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Lexicon Pharmaceuticals is LXRX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Lexicon Pharmaceuticals Stock?
Lexicon Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Lexicon Pharmaceuticals Stock.

What's the current price of Lexicon Pharmaceuticals Stock?
As of the end of day on the Apr 26, 2024, the price of an Lexicon Pharmaceuticals (LXRX) share was $1.58.

What is the 52-week high and low for Lexicon Pharmaceuticals Stock?
The 52-week high for Lexicon Pharmaceuticals Stock is $3.79 and the 52-week low is $0.92.

What is the market capitalization of Lexicon Pharmaceuticals Stock?
As of the Apr 26, 2024, the market capitalization of Lexicon Pharmaceuticals is 389.054M.

When is the next earnings date for Lexicon Pharmaceuticals?
The upcoming earnings date for Lexicon Pharmaceuticals is May 07, 2024.
Click to get the best stock tips daily for free!

About Lexicon Pharmaceuticals

Lexicon Pharmaceuticals Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain. The compan... LXRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT